Chemically modified tetracyclines can inhibit proteins overexpressed by aggressive melanoma cells. This finding offers a potential new therapeutic strategy for targeting melanoma progression.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: